Mark Gibbs
Family Medicine · Gainesville, TXNPI 1619959004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,651 and has fallen 65.9% since, to $563 in 2021.
Across 241 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$534
- Pfizer$481
- AstraZeneca$454
- Novo Nordisk$376
- Amgen$205
- Sanofi-aventis U.S. LLC$193
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,577100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 35 | $534 |
| Pfizer | 35 | $481 |
| AstraZeneca | 29 | $454 |
| Novo Nordisk | 35 | $376 |
| Amgen | 12 | $205 |
| Sanofi-aventis U.S. LLC | 11 | $193 |
| Boehringer Ingelheim | 12 | $186 |
| Lilly USA, LLC | 11 | $170 |
| Antares Pharma, Inc. | 7 | $136 |
| Merck | 9 | $124 |
| AbbVie(2 entities) | 7 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $78 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Eisai Inc. | 3 | $54 |
| Johnson & Johnson | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Genentech USA, Inc. | 2 | $32 |
| Shire North American Group Inc | 2 | $27 |
| Mylan Specialty L.p. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Vertiflex, Inc. | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Strongbridge US Inc. | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
How this compares
$3,583 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Gainesville
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.